Drug intelligence / Profile preview

fumaria indica extract

Development stage
Preclinical
Administration
Oral
01

Overview

**Fumaria indica extract** is a herbal preparation obtained from the whole or part of the Fumaria indica (Hausskn.) Pugsley plant, used traditionally in Ayurvedic medicine and other regional traditional systems. The extract contains a complex mixture of bioactive phytochemicals, including isoquinoline alkaloids (e.g., protopine, fumariline, bicuculine), steroids (e.g., sitosterol, stigmasterol), coumarins, flavonoids, organic acids (e.g., methyl fumarate), and other secondary metabolites[3][7]. It has demonstrated a variety of pharmacological activities in experimental models, such as: - **Smooth muscle relaxant** effects, comparable to papaverine, likely via calcium channel antagonism and/or interaction with muscarinic/cholinergic pathways (protopine as one main mechanism)[3]. - **Hepatoprotective** effects, possibly through free radical scavenging and modulation of key liver enzymes, with significant activity attributed to protopine and methyl fumarate[3]. - **Laxative, diuretic, blood purification, and vermifuge** actions have been noted in traditional medicine[1][5]. - **Psychopharmacological activities** (anti-aggressive and anxiolytic effects), with activity profiles depending on CNS functional state and requiring repeated dosing[5]. - **Cardioprotective** and **hypotensive effects**, proposed mechanisms may involve endothelial function modulation and interaction with cardiovascular signaling pathways[4][7]. Specific pharmacological mechanisms involve multiple targets but are not identical to any single class of psychoactive pharmaceuticals[5]. The extract is under study for potential as a phyto-pharmaceutical for mental health and chronic physical disorders.

Brand names
fumaria indica extract
Other names
Fumaria indica hydromethanolic extractFumaria indica hydroalcoholic extractFumitory extract (from Fumaria indica)Fumaria indica Hausskn. extract
02

Targets

CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)mAChR (Muscarinic acetylcholine receptors)Acetylcholinesterase

Beyond the preview

Go deeper on fumaria indica extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fumaria indica extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call